Practical and Efficient Synthesis of 2-Thio-imidazole Derivative-ZY12201: A Potent TGR5 Agonist
- 21 August 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (8), 1508-1514
- https://doi.org/10.1021/acs.oprd.0c00234
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Identification of an Orally Efficacious GPR40/FFAR1 Receptor AgonistACS Medicinal Chemistry Letters, 2016
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid LoadingCell Metabolism, 2011
- Diabesity: an overview of a rising epidemicNephrology Dialysis Transplantation, 2010
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disordersDrug Discovery Today, 2009
- Non-insulin therapies for type 2 diabetesNature Reviews Drug Discovery, 2007
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activationNature, 2006
- Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1Biochemical and Biophysical Research Communications, 2005
- Pharmacological Agents That Directly Modulate Insulin SecretionPharmacological Reviews, 2003
- Identification of membrane-type receptor for bile acids (M-BAR)Biochemical and Biophysical Research Communications, 2002